已发表的部分文献: 标题:The protective role of DOT1L in UV-induced melanomagenesis.作者:Zhu B, Chen S, Wang H, Yin C, Han C, Peng C, Liu Z, Wan L, Zhang X, Zhang J, Lian CG, Ma P, Xu ZX, Prince S, Wang T, Gao X, Shi Y, Liu D, Liu M, Wei W, Wei Z, Pan J, Wang Y, Xuan Z, Hess J, Hayward NK, Goding CR, Chen X, Zhou J, Cui R;杂志名称:Nat Commun 标题:Epigenetic control of influenza virus: role of H3K79 methylation in interferon-induced antiviral response.作者:Marcos-Villar L, DÃaz-Colunga J, Sandoval J, Zamarreño N, Landeras-Bueno S, Esteller M, Falcón A, Nieto A;杂志名称:Sci Rep 标题:Interferon-ï¢ Stimulation Elicited by the Influenza Virus Is Regulated by the Histone Methylase Dot1L through the RIG-I-TRIM25 Signaling Axis.作者:Marcos-Villar L, Nistal-Villan E, Zamarreño N, Garaigorta U, Gastaminza P, Nieto A;杂志名称:Cells 标题:Perinatal inflammation alters histone 3 and histone 4 methylation patterns: Effects of MiR-29b supplementation.作者:Sugar SS, Heyob KM, Cheng X, Lee RJ, Rogers LK;杂志名称:Redox Biol Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。